Predict strengthens national footprint with new Rome office

Predict S.P.A. Class B ( (IT:PRE) ) has issued an update.

Predict S.p.A., an Italian med-tech SME specializing in in vivo diagnostics, breath analysis technologies, and digital healthcare, has built a portfolio of innovative solutions for non-invasive cancer screening, AI-driven robotic support, and holopresence communication for clinicians and educators. With long-standing collaborations with leading Italian university hospitals and research institutes, the company has expanded beyond its Bari headquarters with offices in Milan and now Rome, consolidating its footprint along the country’s main innovation axis.

Predict has opened a new representative office in Rome, operational from 1 April 2026, to strengthen ties with institutions, large companies, technology players, and the capital’s public–private innovation ecosystem. The move, which completes a national presence along the Bari–Rome–Milan corridor, is intended to bring the company closer to key stakeholders, ensure more uniform coverage of Northern, Central, and Southern Italy, and support its growth strategy by unlocking new collaboration and business opportunities in one of Italy’s primary decision-making centers.

The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.

More about Predict S.P.A. Class B

Predict S.p.A. is an Italian innovative SME in the med-tech sector focused on in vivo diagnostics, distributing ultrasound and radiological equipment and developing technologies in breath analysis and digital healthcare. Founded in 2008 in Bari, it operates through four business units spanning diagnostic imaging support, breath-based diagnostics, and augmented reality and robotics solutions for clinicians and industry professionals.

The company has created proprietary platforms such as Mistral for non-invasive oncological screening via breath analysis, Aphel for AI-powered robotic support in hospitals and education, and Optip for holopresence-based remote medical consultation, training, and events. Leveraging partnerships with major university hospitals and research institutes across Italy, Predict has expanded from its Bari headquarters to offices in Milan and Rome, reinforcing its presence in key healthcare and innovation hubs.

Average Trading Volume: 26,890

Technical Sentiment Signal: Hold

Current Market Cap: €5.91M

See more insights into PRE stock on TipRanks’ Stock Analysis page.